Safety and feasibility of a lower dose intravenous TPA therapy for ischemic stroke beyond the first three hours.
about
Advances in ischemic stroke treatment: neuroprotective and combination therapies.Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence.Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-κB-mediated inflammatory responses.Alteplase for acute ischemic stroke.Does long-term continuous transcranial Doppler monitoring require a pause for safer use?Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
P2860
Safety and feasibility of a lower dose intravenous TPA therapy for ischemic stroke beyond the first three hours.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Safety and feasibility of a lo ...... beyond the first three hours.
@en
Safety and feasibility of a lo ...... beyond the first three hours.
@nl
type
label
Safety and feasibility of a lo ...... beyond the first three hours.
@en
Safety and feasibility of a lo ...... beyond the first three hours.
@nl
prefLabel
Safety and feasibility of a lo ...... beyond the first three hours.
@en
Safety and feasibility of a lo ...... beyond the first three hours.
@nl
P2093
P2860
P356
P1476
Safety and feasibility of a lo ...... beyond the first three hours.
@en
P2093
Ashraf El-Mitwalli
James C Grotta
Lewis B Morgenstern
Zsolt Garami
P2860
P304
P356
10.1159/000084090
P577
2005-02-22T00:00:00Z